Iterum Therapeutics PLC (NASDAQ:ITRM) Stock Soars 61% After Approval of ORLYNVAH™
This morning investors are going to look into those stocks that may have clocked strong gains last Friday, and one of the stocks that could be in focus is that of Iterum Therapeutics PLC (NASDAQ:ITRM). Following an announcement from the company, the stock soared by 61% for the day. Product Approval On Friday, the company announced that its new drug ORLYNVAH had been approved by the United States Food and…